The general pooled analysis showed a statistically substantial percent decrease in body weight of the retatrutide group when contrasted to the placebo team after 36 weeks of treatment, with a total MD of − 14.33 (95% CI: − 18.27 to …
Not a member yet? Register now
Are you a member? Login now